FTC challenges patents held by nine big drugmakers, citing unfair competition
The agency claims intellectual property for emergency allergy shot EpiPen and asthma medication Advair was “improperly listed” in a Food and Drug Administration database.
The agency claims intellectual property for emergency allergy shot EpiPen and asthma medication Advair was “improperly listed” in a Food and Drug Administration database.
The move could further integrate the retail giant’s healthcare ambitions with its core ecommerce business.
The tech retailer notched similar partnerships to co-develop home care products with Geisinger and Atrium earlier this year.
The physician staffing firm, which filed for Chapter 11 bankruptcy this spring, said it has since reduced its debt by more than 70%.
The deal comes months after Surescripts settled a yearslong antitrust case with the Federal Trade Commission.
The new proposed rule is meant to stop brokers from steering beneficiaries to plans based on excessive compensation. It’s regulators’ latest move to curb Medicare Advantage marketing misconduct following a push from lawmakers.
Kaiser reported a $239 million profit and $83 million in investment income, compared to multi-billion dollar losses in the same period last year.
As extreme weather events caused by climate change ramp up in frequency, hospitals are struggling with financial and data challenges in disaster planning.
Dealing with natural disasters, severe weather, active shooters and other events requires hospital staff to coordinate with multiple outside agencies. But communicating with stakeholders can be a challenge.
Regulators finalized a number of rules Thursday with sweeping implications for providers in the Medicare program, including rates for next year that doctors and hospitals slammed as insufficient.